Selected research
Industry Research
MRI Contrast Agents Industry Research Report 2026
Market perspective
The global MRI Contrast Agents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for MRI Contrast Agents is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for MRI Contrast Agents is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for MRI Contrast Agents is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of MRI Contrast Agents include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global MRI Contrast Agents market in revenue (US$ million) and, where applicable, sales volume (Liter), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Liter) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to MRI Contrast Agents.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
MRI Contrast Agents Market by Company
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
MRI Contrast Agents Segment by Type
Gadobutrol
Gadoterate Meglumine
Gadobenate Dimeglumine
Gadopentetate Dimeglumine
Gadoteridol
Gadodiamine
Others
MRI Contrast Agents Segment by Application
Hospitals
Clinics
MRI Contrast Agents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global MRI Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of MRI Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of MRI Contrast Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of MRI Contrast Agents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of MRI Contrast Agents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of MRI Contrast Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gadobutrol
- Gadoterate Meglumine
- Gadobenate Dimeglumine
- Gadopentetate Dimeglumine
- Gadoteridol
- Gadodiamine
- Others
Applications
- Hospitals
- Clinics
Companies covered
- Bayer
- Guerbet Group
- Bracco Imaging
- GE Healthcare
- BeiLu Pharma
- Hengrui Medicine
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 MRI Contrast Agents by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Gadobutrol
- 2.2.3 Gadoterate Meglumine
- 2.2.4 Gadobenate Dimeglumine
- 2.2.5 Gadopentetate Dimeglumine
- 2.2.6 Gadoteridol
- 2.2.7 Gadodiamine
- 2.2.8 Others
- 2.3 MRI Contrast Agents by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Hospitals
- 2.3.3 Clinics
- 2.4 Global Market Growth Prospects
- 2.4.1 Global MRI Contrast Agents Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global MRI Contrast Agents Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global MRI Contrast Agents Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global MRI Contrast Agents Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global MRI Contrast Agents Production by Manufacturers (2021-2026)
- 3.2 Global MRI Contrast Agents Production Value by Manufacturers (2021-2026)
- 3.3 Global MRI Contrast Agents Average Price by Manufacturers (2021-2026)
- 3.4 Global MRI Contrast Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global MRI Contrast Agents Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global MRI Contrast Agents Manufacturers, Product Type & Application
- 3.7 Global MRI Contrast Agents Manufacturers Established Date
- 3.8 Global MRI Contrast Agents Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bayer
- 4.1.1 Bayer MRI Contrast Agents Company Information
- 4.1.2 Bayer MRI Contrast Agents Business Overview
- 4.1.3 Bayer MRI Contrast Agents Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Bayer Product Portfolio
- 4.1.5 Bayer Recent Developments
- 4.2 Guerbet Group
- 4.2.1 Guerbet Group MRI Contrast Agents Company Information
- 4.2.2 Guerbet Group MRI Contrast Agents Business Overview
- 4.2.3 Guerbet Group MRI Contrast Agents Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Guerbet Group Product Portfolio
- 4.2.5 Guerbet Group Recent Developments
- 4.3 Bracco Imaging
- 4.3.1 Bracco Imaging MRI Contrast Agents Company Information
- 4.3.2 Bracco Imaging MRI Contrast Agents Business Overview
- 4.3.3 Bracco Imaging MRI Contrast Agents Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Bracco Imaging Product Portfolio
- 4.3.5 Bracco Imaging Recent Developments
- 4.4 GE Healthcare
- 4.4.1 GE Healthcare MRI Contrast Agents Company Information
- 4.4.2 GE Healthcare MRI Contrast Agents Business Overview
- 4.4.3 GE Healthcare MRI Contrast Agents Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 GE Healthcare Product Portfolio
- 4.4.5 GE Healthcare Recent Developments
- 4.5 BeiLu Pharma
- 4.5.1 BeiLu Pharma MRI Contrast Agents Company Information
- 4.5.2 BeiLu Pharma MRI Contrast Agents Business Overview
- 4.5.3 BeiLu Pharma MRI Contrast Agents Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 BeiLu Pharma Product Portfolio
- 4.5.5 BeiLu Pharma Recent Developments
- 4.6 Hengrui Medicine
- 4.6.1 Hengrui Medicine MRI Contrast Agents Company Information
- 4.6.2 Hengrui Medicine MRI Contrast Agents Business Overview
- 4.6.3 Hengrui Medicine MRI Contrast Agents Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Hengrui Medicine Product Portfolio
- 4.6.5 Hengrui Medicine Recent Developments
5 Global MRI Contrast Agents Production by Region
- 5.1 Global MRI Contrast Agents Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global MRI Contrast Agents Production by Region: 2021-2032
- 5.2.1 Global MRI Contrast Agents Production by Region: 2021-2026
- 5.2.2 Global MRI Contrast Agents Production Forecast by Region (2027-2032)
- 5.3 Global MRI Contrast Agents Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global MRI Contrast Agents Production Value by Region: 2021-2032
- 5.4.1 Global MRI Contrast Agents Production Value by Region: 2021-2026
- 5.4.2 Global MRI Contrast Agents Production Value Forecast by Region (2027-2032)
- 5.5 Global MRI Contrast Agents Market Price Analysis by Region (2021-2026)
- 5.6 Global MRI Contrast Agents Production and Value, YOY Growth
- 5.6.1 North America MRI Contrast Agents Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe MRI Contrast Agents Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China MRI Contrast Agents Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan MRI Contrast Agents Production Value Estimates and Forecasts (2021-2032)
6 Global MRI Contrast Agents Consumption by Region
- 6.1 Global MRI Contrast Agents Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global MRI Contrast Agents Consumption by Region (2021-2032)
- 6.2.1 Global MRI Contrast Agents Consumption by Region: 2021-2026
- 6.2.2 Global MRI Contrast Agents Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America MRI Contrast Agents Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe MRI Contrast Agents Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific MRI Contrast Agents Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa MRI Contrast Agents Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global MRI Contrast Agents Production by Type (2021-2032)
- 7.1.1 Global MRI Contrast Agents Production by Type (2021-2032) & (Liter)
- 7.1.2 Global MRI Contrast Agents Production Market Share by Type (2021-2032)
- 7.2 Global MRI Contrast Agents Production Value by Type (2021-2032)
- 7.2.1 Global MRI Contrast Agents Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global MRI Contrast Agents Production Value Market Share by Type (2021-2032)
- 7.3 Global MRI Contrast Agents Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global MRI Contrast Agents Production by Application (2021-2032)
- 8.1.1 Global MRI Contrast Agents Production by Application (2021-2032) & (Liter)
- 8.1.2 Global MRI Contrast Agents Production Market Share by Application (2021-2032)
- 8.2 Global MRI Contrast Agents Production Value by Application (2021-2032)
- 8.2.1 Global MRI Contrast Agents Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global MRI Contrast Agents Production Value Market Share by Application (2021-2032)
- 8.3 Global MRI Contrast Agents Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 MRI Contrast Agents Value Chain Analysis
- 9.1.1 MRI Contrast Agents Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 MRI Contrast Agents Production Mode & Process
- 9.2 MRI Contrast Agents Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 MRI Contrast Agents Distributors
- 9.2.3 MRI Contrast Agents Customers
10 Global MRI Contrast Agents Analyzing Market Dynamics
- 10.1 MRI Contrast Agents Industry Trends
- 10.2 MRI Contrast Agents Industry Drivers
- 10.3 MRI Contrast Agents Industry Opportunities and Challenges
- 10.4 MRI Contrast Agents Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst